newsfilter
← Latest News
GlobeNewswire·

Chembio Diagnostics Announces Expansion of Direct-to-Consumer Commercial Channel

HAUPPAUGE, N.Y., June 15, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Chembio) (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the launch of its direct-to-consumer commercial channel